Prestige Consumer Healthcare Inc.
General ticker "PBH" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $3.1B (TTM average)
Prestige Consumer Healthcare Inc. does not follow the US Stock Market performance with the rate: -38.0%.
Estimated limits based on current volatility of 2.2%: low 46.40$, high 48.53$
Factors to consider:
- Total employees count: 570 (+1.8%) as of 2024
- US accounted for 78.8% of revenue in the fiscal year ended 2024-03-31
- Top business risk factors: Third-party risks, Market competition, Cybersecurity threats, Geopolitical risks, Product development risks
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [49.26$, 69.40$]
- 2027-03-31 to 2028-03-30 estimated range: [47.60$, 67.61$]
Financial Metrics affecting the PBH estimates:
- Negative: with PPE of 13.8 at the end of fiscal year the price was high
- Positive: 6.59 < Operating cash flow per share per price, % of 8.79
- Positive: Operating profit margin, % of 28.42 > 18.39
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 5.16
- Positive: -9.55 < Industry operating profit margin (median), % of 1.02
- Negative: Industry earnings per price (median), % of 3.52 <= 4.45
- Positive: Interest expense per share per price, % of 1.44 <= 3.31
- Positive: -14.17 < Investing cash flow per share per price, % of -4.67
Short-term PBH quotes
Long-term PBH plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $1,125.36MM | $1,137.76MM | $1,088.70MM |
| Operating Expenses | $782.93MM | $800.99MM | $779.30MM |
| Operating Income | $342.43MM | $336.77MM | $309.41MM |
| Non-Operating Income | $-66.40MM | $-52.59MM | $-51.91MM |
| Interest Expense | $67.16MM | $47.63MM | $42.34MM |
| Income(Loss) | $276.02MM | $284.19MM | $257.50MM |
| Taxes | $66.69MM | $69.58MM | $67.19MM |
| Net Income(Loss)* | $209.34MM | $214.60MM | $190.30MM |
| Stockholders Equity | $1,655.08MM | $1,834.90MM | $1,887.52MM |
| Inventory | $138.72MM | $147.71MM | $159.13MM |
| Assets | $3,318.42MM | $3,402.22MM | $3,494.31MM |
| Operating Cash Flow | $248.93MM | $251.51MM | $257.63MM |
| Capital expenditure | $9.55MM | $8.22MM | $11.18MM |
| Investing Cash Flow | $-20.11MM | $-17.45MM | $-136.84MM |
| Financing Cash Flow | $-241.01MM | $-182.07MM | $-156.06MM |
| Earnings Per Share** | $4.21 | $4.32 | $3.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.